Literature DB >> 18177275

Obesity in schizophrenia: screening, monitoring, and health promotion.

Lora Humphrey Beebe1.   

Abstract

PURPOSE: This paper reviews risks, assessments, antipsychotic medication choices, and lifestyle interventions for obesity in persons with schizophrenia.
CONCLUSIONS: Antipsychotic medication is the most important treatment choice. Simple diet teaching must take into account the cognitive limitations of clients with schizophrenia. After medical clearance is obtained, moderate exercise can be encouraged. Education about exercise benefits may increase motivation. PRACTICE IMPLICATIONS: Nurses would be remiss to ignore the physical health effects of obesity in schizophrenia. Practitioners must choose psychiatric medications and provide health education, health promotion, and appropriate referrals to optimize quality of life for this group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177275     DOI: 10.1111/j.1744-6163.2008.00144.x

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  5 in total

1.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

Review 2.  Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review.

Authors:  Nick Verhaeghe; Jan De Maeseneer; Lea Maes; Cornelis Van Heeringen; Lieven Annemans
Journal:  Int J Behav Nutr Phys Act       Date:  2011-04-11       Impact factor: 6.457

3.  The Relationship between Community Participation and Physical Activity among Individuals with Serious Mental Illnesses.

Authors:  Gretchen Snethen; Eugene Brusilovskiy; Bryan P McCormick; Shiv V Hiremath; Mark S Salzer
Journal:  Ment Health Phys Act       Date:  2021

4.  The effectiveness of specialist roles in mental health metabolic monitoring: a retrospective cross-sectional comparison study.

Authors:  Brian McKenna; Trentham Furness; Elizabeth Wallace; Brenda Happell; Robert Stanton; Chris Platania-Phung; Karen-leigh Edward; David Castle
Journal:  BMC Psychiatry       Date:  2014-09-02       Impact factor: 3.630

5.  Schizotypy, Lifestyle Behaviors, and Health Indicators in a Young Adult Sample.

Authors:  Thomas J Dinzeo; Uma Thayasivam
Journal:  Behav Sci (Basel)       Date:  2021-12-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.